Empowered Funds LLC Grows Holdings in DaVita Inc. (NYSE:DVA)

Empowered Funds LLC grew its position in shares of DaVita Inc. (NYSE:DVA) by 856.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 55,698 shares of the company’s stock after buying an additional 49,874 shares during the quarter. Empowered Funds LLC’s holdings in DaVita were worth $8,330,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Wedmont Private Capital boosted its position in DaVita by 4.4% in the third quarter. Wedmont Private Capital now owns 1,776 shares of the company’s stock worth $280,000 after purchasing an additional 75 shares during the last quarter. Clarius Group LLC purchased a new position in shares of DaVita in the 3rd quarter worth about $208,000. Livforsakringsbolaget Skandia Omsesidigt grew its position in DaVita by 295.9% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 669 shares of the company’s stock valued at $110,000 after buying an additional 500 shares during the period. Exchange Traded Concepts LLC purchased a new stake in DaVita during the third quarter worth about $135,000. Finally, Thurston Springer Miller Herd & Titak Inc. raised its position in DaVita by 27.3% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 1,630 shares of the company’s stock worth $267,000 after acquiring an additional 350 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Barclays raised their price target on shares of DaVita from $150.00 to $164.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $161.80.

DaVita Trading Up 0.8 %

Shares of DVA opened at $173.45 on Monday. The firm has a market cap of $14.22 billion, a P/E ratio of 18.71, a price-to-earnings-growth ratio of 0.84 and a beta of 0.94. DaVita Inc. has a fifty-two week low of $108.76 and a fifty-two week high of $179.60. The company has a debt-to-equity ratio of 15.78, a quick ratio of 1.33 and a current ratio of 1.37. The business has a 50-day moving average of $160.59 and a 200 day moving average of $156.53.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.